Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

12

Revenue 2017

Bayer

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Bayer's 2013 sales performance.

Bayer

CHMP backs Bayer’s tumour-agnostic drug Vitrakvi

CHMP backs Bayer’s tumour-agnostic drug Vitrakvi GW Pharma’s Epidyolex also on the recommended list. Bayer’s Vitrakvi has become the first drug in Europe recommended to treat cancer based on a molecular signature, rather than where

Re-imagining content supply chains for a next-gen customer experience in pharma

Re-imagining content supply chains for a next-gen customer experience in pharma According to Uwe Dalichow, Head of Global Marketing Operations at Bayer and a member of the Digital Council: “The traditional way of creating and disseminating content in many pharma companies today

BioNTech raises €290m for mRNA cancer vaccine platform

BioNTech raises €290m for mRNA cancer vaccine platform Bayer – says it will use a chunk of the proceeds to push its lead melanoma candidate through clinical development.

M&F Health, 90TEN and Sanofi among big winners at Communiqué Awards

M&F Health, 90TEN and Sanofi among big winners at Communiqué Awards Winner: Tackle TD. by Virgo Health for Bayer. 15. Excellence in Communication Through Creative Execution.

At Tipping Point – Tracking Year-on-Year Cuts and Closures in Contraception

by Incisive Health for Advisory Group on Contraception, supported by Bayer Plc and MSD. ... At Tipping Point – Tracking Year-on-Year Cuts and Closures in Contraception - by Incisive Health for Advisory Group on Contraception, supported by Bayer Plc and

[ Previous 5 results ] 4 5 6 7 8 9 10 11 12 13 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Frontera Group

Welcome to Frontera Group, where our agencies immerse you in the world of the patient...

Latest intelligence

Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...
How will the Tories’ historic win shape the NHS?
Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of December’s General Election result on 2020 and beyond...
CSR 'Christmas Spirit' 2019
OPEN Health champions CSR over Christmas by giving back to the community and increasing our activities and efforts...

Infographics